Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 410 participants.
Also called NCT02425371
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 410 participants
- Registry
-
NCT02425371
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Unknown status
Technical summary
Registry record NCT02425371. Randomized; single masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)
- Acronym
- OPTIMIZE-HFPEF
- Condition
- Heart Failure, Diastolic
- Intervention (Other)
- Screening and treatment of comorbidities
- Intervention (Other)
- Placebo Comparator
- Lead sponsor
- Göteborg University
- Collaborator
- Umeå University
- Collaborator
- Karolinska Institutet
- Collaborator
- Uppsala University
- Collaborator
- Vastra Gotaland Region
Record details
- Record id
cardio:ct-nct02425371- Content hash
fd82b42ded9f54c142c28f40f5ee5ceabd0e501f7d49eda4abb84cb18775b903